• Explore /
  • Poster
  • / A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis.

A phase 1b study with selinexor, a first in class selective inhibitor of nuclear export (SINE) in patients with advanced sarcomas: An efficacy analysis.

Abstract Poster

Authors

null

Mrinal M. Gounder

Memorial Sloan Kettering Cancer Center, New York, NY

Mrinal M. Gounder , Alona Zer , William D. Tap , Abha A. Gupta , Mary Louise Keohan , Mark Andrew Dickson , Sandra P. D'Angelo , Ping Chi , Lanier R. Tanner , Theresa Konen , Tami Rashal , Dilara McCauley , Jean-Richard Saint-Martin , Robert Carlson , Tracey Marshall , Sharon Shacham , Mansoor Raza Mirza , Michael Kauffman , Gary Schwartz , Albiruni R. A. Razak

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT01896505

Citation

J Clin Oncol 33, 2015 (suppl; abstr 10569)

DOI

10.1200/jco.2015.33.15_suppl.10569

Abstract #

10569

Poster Bd #

213

Abstract Disclosures

Similar Posters

First Author: Mrinal M. Gounder

First Author: Ulrik Niels Lassen

First Author: Morten Mau-Soerensen

First Author: Ignace Vergote